BHB (Beta-Hydroxybutyrate) in Oral Pouches

Beta-hydroxybutyrate (BHB) is a ketone body. Supplement BHB is sold as salts, typically sodium, calcium, magnesium, or potassium BHB, often blended. Exogenous ketone products are dosed in grams: commercial servings run about 10 to 12g, and the functional range cited across the literature and the market is roughly 5 to 12g. In the one clinical study that looked closely at taste, Fischer et al. (2018), subjects took 0.5g per kilogram of body weight, about 35g of BHB salt for a 70 kg adult, to reach a barely ketotic blood level.

No. BHB is the clearest case of an ingredient that fails the pouch format on arithmetic alone. PouchMade's standard pouch is 0.6g, with 0.5g and 0.7g formats available, and the typical actives budget is 250 to 280 mg per pouch, about 300 mg at most. Filler, flavor, and sweetener make up the rest. The salt weight, not just the BHB portion, counts against that budget.

• At the full 300 mg maximum, one pouch carries 6 percent of a 5g dose, 3 percent of a 10g serving, and 2.5 percent of 12g.
• Matching a 10 to 12g commercial serving would take about 33 to 40 pouches at 300 mg each.
• Even the whole 0.7g pouch, with no filler or flavor at all, would be less than a tenth of a 10g serving.

No known salt form, particle engineering, or matrix trick closes that gap, and absorption does not help. There is no buccal absorption study for BHB anywhere, and as a charged carboxylate in solution it is a poor theoretical candidate for passing through the mouth lining. What a pouch could hold is a label-appeal inclusion of well under 300 mg with no expectation of a ketone or metabolic effect. That is a different, and much less defensible, product from a functional ketone supplement, and it should be presented that way on the label and in marketing.

In a PouchMade review of about 36 non-nicotine pouch formulas on major US marketplaces in September 2026, none listed BHB or any ketone salt, and a wider scan of about 198 pouch products did not turn it up either. BHB is absent from current pouch products as far as we can find, consistent with the dose math.

Even a token dose brings a real taste problem. BHB salts are consistently described as bitter, salty, sour, and metallic. Subjects in Fischer et al. (2018) called the drink an "extensive sour taste" and "salty and soapy," with an aroma that "reminded of medicine," and that was with an added citric acid flavor system that caused digestive complaints of its own without fixing the taste. The metallic note is linked to activation of the TAS2R7 bitter receptor by metal ions. Taste-masking patents exist specifically for BHB, which tells you the industry treats it as a hard, unsolved problem. In a pouch, the active sits against the gum for the whole session, so there is no swallowing past it.

Handling depends on the salt. Potassium and magnesium BHB are the most hygroscopic; sodium and calcium BHB are more manufacturable. No quantitative moisture-uptake numbers were found publicly, so the salt choice, incoming water content, and finished-blend water activity all need to be settled at the bench.

The core rule is the same as for any dietary ingredient: under 21 CFR 111.75(a)(1), every batch needs at least one appropriate identity test, and a supplier CoA cannot stand in for it. Where no pharmacopeial method is in hand, the practical approach is FTIR against a qualified reference plus an HPLC assay against a certified standard. For BHB specifically, the spec has to name the exact salt or salt blend, because hygroscopicity, taste, and the mineral carried with each serving all change with it.

A useful CoA shows:

• The salt form or blend, matching the spec
• Identity method and reference standard, with an actual assay result
• Water content, given the salt-dependent hygroscopicity
• Lead, arsenic, cadmium, and mercury by ICP-MS under USP <2232> and <233>
• Microbial counts under USP <2021>, <2022>, and <2023>

In the European Union, EFSA issued a negative novel food opinion in 2022 on a sodium, magnesium, and calcium BHB blend. The stated reasons were data quality and procedure rather than a toxicology signal, and EFSA separately proposed a 6g per day ceiling, itself below the amounts associated with a felt effect. The US new dietary ingredient status of BHB salts is not established in the sources reviewed for this guide, so treat it as unsettled and have the ingredient supplier document the US regulatory basis before launch.

Claims are the bigger risk for a BHB pouch. The FTC expects competent and reliable scientific evidence for a claim, and no pouch can carry a dose that the ketone literature supports. Any keto, ketosis, fat-burning, or metabolic claim for a BHB pouch would be unsupported at pouch doses. If BHB appears at all, keep the claims structure/function, tied to the whole formula, with the DSHEA disclaimer, and state the milligram amount.

For a brand with a metabolic or keto positioning, the better path is a functional pouch built on actives that fit the budget at a studied dose, rather than a ketone pouch that cannot deliver one. PouchMade formulates custom stacks through custom formulation at its FDA-registered, GMP-certified facility in Dallas, Texas. The first check for any requested ingredient is its dose against the actives budget, before any bench work. Other gram-dose ingredients, such as creatine and L-citrulline, run into the same wall. For how a functional launch comes together, read how to launch a functional pouch brand.